Clinical Trial Detail

NCT ID NCT01446809
Title Pazopanib Hydrochloride Followed By Chemotherapy and Surgery in Treating Patients With Soft Tissue Sarcoma
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements no
Sponsors University of Washington
Indications

histiocytoma

chondrosarcoma

leiomyosarcoma

rhabdomyosarcoma

alveolar soft part sarcoma

synovial sarcoma

dermatofibrosarcoma protuberans

adult epithelioid sarcoma

sarcoma

angiosarcoma

neurofibrosarcoma

fibrous histiocytoma

adult fibrosarcoma

adult malignant hemangiopericytoma

adult liposarcoma

Therapies

Doxorubicin + Ifosfamide

Pazopanib + Doxorubicin + Ifosfamide

Age Groups: adult

No variant requirements are available.